DMK Pharmaceuticals (DMK) Restructures Executive Team
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/29/2026
- S&P 500, Nasdaq futures inch up before Fed decision; chip stocks wobble
- Oil rises as US-Iran tension escalates after Iraq strikes, missile attack
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- Market watchers weigh chances of a surprise Fed rate hike tomorrow
- U.S. chip stocks extend losses on AI financing, China competition fears
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- HF Sinclair plans to spin off lubricants unit, close Canadian refinery
- S&P 500 ends higher as investors await tech earnings
- SoFi Technologies (SOFI) Tops Q2 EPS by 1c ; Offers Guidance
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
- After-Hours Stock Movers: GOOGL, TSLA, NOW, IBM, TXN, MOH, URI
- After-Hours Stock Movers: SMCI, OKLO, XE, PEGA, CLDX, ALK
DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
October 19, 2023 4:05 PM EDTSeth Cohen is appointed Chief Financial Officer, bringing over thirty years of financial industry experience to DMK, and seasoned corporate lawyer John Dorbin assumes role of General Counsel Corporate Secretary
Appointments strengthen leadership team and provide financial and corporate expertise as the organization focuses on improving DMKs existing commercial product portfolio and reducing opioid related deaths
SAN DIEGO, Oct. 19, 2023 (GLOBE NEWSWIRE) --... More
